Exact Mass: 315.1331

Exact Mass Matches: 315.1331

Found 91 metabolites which its exact mass value is equals to given mass value 315.1331, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Neosaxitoxin

[(4R,10aS,10bS)-2-amino-5,10,10-trihydroxy-6-imino-3H,4H,5H,6H,8H,9H,10H,10bH-pyrrolo[1,2-c]purin-4-yl]methyl carbamate

C10H17N7O5 (315.1291)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents Neosaxitoxin is produced by Protogonyaulax and found in shellfis D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals

   

Clavamycin D

Antibiotic CA 146A

C13H21N3O6 (315.143)


   

N'-Hydroxysaxitoxin

{10,10-dihydroxy-2,6-diimino-hexahydro-1H-pyrrolo[1,2-c]purin-4-yl}methyl N-hydroxycarbamate

C10H17N7O5 (315.1291)


N-Hydroxysaxitoxin is isolated from the crab Zosimus aeneus. Isolated from the crab Zosimus aeneus.

   

6-Amino-9-benzyl-2-(2-methoxyethoxy)-9H-purin-8-ol

6-amino-9-benzyl-2-(2-methoxyethoxy)-8,9-dihydro-7H-purin-8-one

C15H17N5O3 (315.1331)


   

Di-deacetyl adrogolide

15-propyl-14-thia-11-azatetracyclo[8.7.0.0^{2,7}.0^{13,17}]heptadeca-2,4,6,13(17),15-pentaene-4,5-diol

C18H21NO2S (315.1293)


   

18,19-Dihydroangustine

18,19-Dihydroangustine

C20H17N3O (315.1372)


   

3,14-Dihydroangustine

3,14-Dihydroangustine

C20H17N3O (315.1372)


   
   

Aplidiopsamine A

Aplidiopsamine A

C17H13N7 (315.1232)


   

parazoanthine B

parazoanthine B

C15H17N5O3 (315.1331)


   

11Beta-hydroxy-saxitoxin|11Beta-OH-STX|M2

11Beta-hydroxy-saxitoxin|11Beta-OH-STX|M2

C10H17N7O5 (315.1291)


   

Dopamine 3-O-glucoside

Dopamine 3-O-glucoside

C14H21NO7 (315.1318)


   
   
   
   
   
   
   
   
   
   

N'-Hydroxysaxitoxin

N'-Hydroxysaxitoxin

C10H17N7O5 (315.1291)


   

2,6-bis(phenylmethoxy)benzonitrile

2,6-bis(phenylmethoxy)benzonitrile

C21H17NO2 (315.1259)


   

[4-(4-fluoro-phenyl)-piperazin-1-yl]-pyridin-4-yl-acetic acid

[4-(4-fluoro-phenyl)-piperazin-1-yl]-pyridin-4-yl-acetic acid

C17H18FN3O2 (315.1383)


   

(R)-3-[((tert-Butoxy)carbonyl)amino]-4-(2,5-difluorophenyl)butanoic acid

(R)-3-[((tert-Butoxy)carbonyl)amino]-4-(2,5-difluorophenyl)butanoic acid

C15H19F2NO4 (315.1282)


   

[4-(4-fluoro-phenyl)-piperazin-1-yl]-pyridin-3-yl-acetic acid

[4-(4-fluoro-phenyl)-piperazin-1-yl]-pyridin-3-yl-acetic acid

C17H18FN3O2 (315.1383)


   

N-(3-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

N-(3-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

C19H22ClNO (315.139)


   

N-(2-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

N-(2-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

C19H22ClNO (315.139)


   

5,6,7,8-TETRAHYDRO-6-(PHENYLMETHYL)-4H-THIENO[2,3-D]AZEPINE-2-CARBOXYLIC ACID, ETHYL ESTER

5,6,7,8-TETRAHYDRO-6-(PHENYLMETHYL)-4H-THIENO[2,3-D]AZEPINE-2-CARBOXYLIC ACID, ETHYL ESTER

C18H21NO2S (315.1293)


   

METHYL (2R)-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-(2,5-DIFLUOROPHENYL)PROPANOATE

METHYL (2R)-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-(2,5-DIFLUOROPHENYL)PROPANOATE

C15H19F2NO4 (315.1282)


   

(3R)-3-[(tert-Butoxycarbonyl)amino]-4-(2,4-difluorophenyl)butanoic acid

(3R)-3-[(tert-Butoxycarbonyl)amino]-4-(2,4-difluorophenyl)butanoic acid

C15H19F2NO4 (315.1282)


   

3-((tert-butoxycarbonyl)amino)-4-(2,5-difluorophenyl)butanoic acid

3-((tert-butoxycarbonyl)amino)-4-(2,5-difluorophenyl)butanoic acid

C15H19F2NO4 (315.1282)


   

BOC-(R)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID

BOC-(R)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID

C15H19F2NO4 (315.1282)


   

2-Oxazolidinone,4,5,5-triphenyl-

2-Oxazolidinone,4,5,5-triphenyl-

C21H17NO2 (315.1259)


   

N-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)METHANESULFONAMIDE

N-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)METHANESULFONAMIDE

C13H22BNO5S (315.1312)


   

Fmoc-Ala-OH (2,3,3,3-D4)

Fmoc-Ala-OH (2,3,3,3-D4)

C18H13D4NO4 (315.1409)


   

Benzyl 2-Fluoro-4-Morpholinobenzoate

Benzyl 2-Fluoro-4-Morpholinobenzoate

C18H18FNO3 (315.1271)


   

TERT-BUTYL 3-(2,2-DIMETHYL-4,6-DIOXO-1,3-DIOXAN-5-YL)-3-OXOPROPYLCARBAMATE

TERT-BUTYL 3-(2,2-DIMETHYL-4,6-DIOXO-1,3-DIOXAN-5-YL)-3-OXOPROPYLCARBAMATE

C14H21NO7 (315.1318)


   

h-val-tyr-nh2 hcl

h-val-tyr-nh2 hcl

C14H22ClN3O3 (315.135)


   

metoclopramide N-oxide

metoclopramide N-oxide

C14H22ClN3O3 (315.135)


   

(R)-4,5,5-TRIPHENYLOXAZOLIDIN-2-ONE

(R)-4,5,5-TRIPHENYLOXAZOLIDIN-2-ONE

C21H17NO2 (315.1259)


   
   

N-(4-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

N-(4-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

C19H22ClNO (315.139)


   

Doxepin hydrochloride

(E)-doxepin hydrochloride

C19H22ClNO (315.139)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D000890 - Anti-Infective Agents > D000935 - Antifungal Agents Doxepin hydrochloride is an orally active tricyclic antidepressant agent. Doxepin hydrochloride is a potent and selective histamine receptor H1 antagonist. Doxepin hydrochloride is also a potent CYP450 inhibitor and significantly inhibits CYP450 2C19 and 1A2[1][2]. Doxepin inhibits reuptake of serotonin and norepinephrine as a tricyclic antidepressant[3].
. Doxepin has therapeutic effects in atopic dermatitis,chronic urticarial,can improve cognitive processes, protect central nervous system[4].
. Doxepin has also been proposed as a protective factor against oxidative stress[5].
.

   

Boc-(S)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid

Boc-(S)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid

C15H19F2NO4 (315.1282)


   

H-Asp(Obzl)-OtBu.HCl

H-Asp(Obzl)-OtBu.HCl

C15H22ClNO4 (315.1237)


   

4-[(4-methoxybenzylidene)amino]azobenzene

4-[(4-methoxybenzylidene)amino]azobenzene

C20H17N3O (315.1372)


   

1-(9,10-DIHYDROANTHRACEN-9-YL)-3-(DIMETHYLAMINO)PROPAN-1-ONE HYDROCHLORIDE

1-(9,10-DIHYDROANTHRACEN-9-YL)-3-(DIMETHYLAMINO)PROPAN-1-ONE HYDROCHLORIDE

C19H22ClNO (315.139)


   

Benzenamine,N-[(4-methoxyphenyl)methylene]-4-(2-phenyldiazenyl)-

Benzenamine,N-[(4-methoxyphenyl)methylene]-4-(2-phenyldiazenyl)-

C20H17N3O (315.1372)


   

Trofinetide

Trofinetide

C13H21N3O6 (315.143)


C78272 - Agent Affecting Nervous System Trofinetide (NNZ-2566), a synthetic analogue of the endogenous N-terminus tripeptide, Glycine-Proline-Glutamate (GPE), has been shown to be neuroprotective in animal models of brain injury.

   

3-Fluoro-4-propyl-[1,1:4,1-terphenyl]-4-carbonitrile

3-Fluoro-4-propyl-[1,1:4,1-terphenyl]-4-carbonitrile

C22H18FN (315.1423)


   

3-METHOXY-4-[3-(1-PYRROLIDINYL)PROPOXY]-BENZOIC ACID HYDROCHLORIDE

3-METHOXY-4-[3-(1-PYRROLIDINYL)PROPOXY]-BENZOIC ACID HYDROCHLORIDE

C15H22ClNO4 (315.1237)


   

(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine

(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine

C16H15F2N5 (315.1295)


   
   

1-(4-Methyl-1-piperidinyl)-2-[(3-methyl-2-quinoxalinyl)thio]ethanone

1-(4-Methyl-1-piperidinyl)-2-[(3-methyl-2-quinoxalinyl)thio]ethanone

C17H21N3OS (315.1405)


   

3H-Pyrazolo[3,4-b]pyridin-3-one, 2,7-dihydro-4,6-dimethyl-2,7-diphenyl-

3H-Pyrazolo[3,4-b]pyridin-3-one, 2,7-dihydro-4,6-dimethyl-2,7-diphenyl-

C20H17N3O (315.1372)


   

N-acetyl-L-glutaminyl-L-glutamine

N-acetyl-L-glutaminyl-L-glutamine

C12H19N4O6- (315.1305)


   

(2S)-2-[[(2S)-2-aminopentanoyl]amino]-3-[[(E)-4-methoxy-4-oxobut-2-enoyl]amino]propanoic acid

(2S)-2-[[(2S)-2-aminopentanoyl]amino]-3-[[(E)-4-methoxy-4-oxobut-2-enoyl]amino]propanoic acid

C13H21N3O6 (315.143)


   

3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-L-Val-OH

3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-L-Val-OH

C13H21N3O6 (315.143)


   
   

FMDP-L-valine

FMDP-L-valine

C13H21N3O6 (315.143)


   

6-(3-furanyl)-N-[(3-methylphenyl)methyl]-4-quinazolinamine

6-(3-furanyl)-N-[(3-methylphenyl)methyl]-4-quinazolinamine

C20H17N3O (315.1372)


   

Val-FMDP

Val-FMDP

C13H21N3O6 (315.143)


A dipeptide composed of 3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanine and L-valine joined by peptide linkages.

   

(4Z)-5-methyl-4-[(1-methylindol-3-yl)methylidene]-2-phenylpyrazol-3-one

(4Z)-5-methyl-4-[(1-methylindol-3-yl)methylidene]-2-phenylpyrazol-3-one

C20H17N3O (315.1372)


   
   
   
   
   
   
   
   
   
   

(2S)-2-amino-N-[(E)-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methylidene]-3-phenylpropanehydrazide (non-preferred name)

(2S)-2-amino-N-[(E)-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methylidene]-3-phenylpropanehydrazide (non-preferred name)

C15H17N5O3 (315.1331)


   

Unii-6yrl8bwd9H

Unii-6yrl8bwd9H

C10H17N7O5 (315.1291)


   

Neosaxitoxin

Neosaxitoxin

C10H17N7O5 (315.1291)


A pyrrolopurine that is saxitoxin carrying a hydroxy substituent on the nitrogen atom at position 5. It is a sodium channel blocker that is undergoing clinical trials as a prolonged-duration local anesthetic.

   

N-Hydroxysaxitoxin

N-Hydroxysaxitoxin

C10H17N7O5 (315.1291)


   

2'-O-MOE-5-Me-rC

2'-O-MOE-5-Me-rC

C13H21N3O6 (315.143)


2'-O-MOE-5-Me-rC is an active compound. 2'-O-MOE-5-Me-rC can be used for oligonucleotide synthesis[1].

   

(3as,4r,10as)-6-amino-10,10-dihydroxy-4-[(c-hydroxycarbonimidoyloxy)methyl]-2-imino-1h,3h,3ah,4h,8h,9h-pyrrolo[1,2-c]purin-5-ium-5-olate

(3as,4r,10as)-6-amino-10,10-dihydroxy-4-[(c-hydroxycarbonimidoyloxy)methyl]-2-imino-1h,3h,3ah,4h,8h,9h-pyrrolo[1,2-c]purin-5-ium-5-olate

C10H17N7O5 (315.1291)


   

9-{3h-pyrrolo[2,3-c]quinolin-4-ylmethyl}purin-6-amine

9-{3h-pyrrolo[2,3-c]quinolin-4-ylmethyl}purin-6-amine

C17H13N7 (315.1232)


   

3-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-2-hydroxy-3-{7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl}propanoic acid

3-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-2-hydroxy-3-{7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl}propanoic acid

C13H21N3O6 (315.143)


   

(2s)-2-[(2-amino-1-hydroxy-3-{[(2e)-1-hydroxy-4-methoxy-4-oxobut-2-en-1-ylidene]amino}propylidene)amino]-3-methylbutanoic acid

(2s)-2-[(2-amino-1-hydroxy-3-{[(2e)-1-hydroxy-4-methoxy-4-oxobut-2-en-1-ylidene]amino}propylidene)amino]-3-methylbutanoic acid

C13H21N3O6 (315.143)


   

[(3as,4r,9r,10as)-9,10,10-trihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid

[(3as,4r,9r,10as)-9,10,10-trihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid

C10H17N7O5 (315.1291)


   

[(3as,4r,10as)-5,10,10-trihydroxy-2,6-diimino-hexahydropyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid

[(3as,4r,10as)-5,10,10-trihydroxy-2,6-diimino-hexahydropyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid

C10H17N7O5 (315.1291)


   

2,2-dimethyl-4,7-diphenyl-1,3-benzoxazol-6-one

2,2-dimethyl-4,7-diphenyl-1,3-benzoxazol-6-one

C21H17NO2 (315.1259)


   

[(3as,4r,9s,10as)-9,10,10-trihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid

[(3as,4r,9s,10as)-9,10,10-trihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid

C10H17N7O5 (315.1291)


   

(2r,3r)-2-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-3-hydroxy-3-[(3s,5r)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]propanoic acid

(2r,3r)-2-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-3-hydroxy-3-[(3s,5r)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]propanoic acid

C13H21N3O6 (315.143)


   

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-3-hydroxy-3-[(3r,5s)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]propanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-3-hydroxy-3-[(3r,5s)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]propanoic acid

C13H21N3O6 (315.143)


   

6-amino-10,10-dihydroxy-4-[(c-hydroxycarbonimidoyloxy)methyl]-2-imino-1h,3h,3ah,4h,8h,9h-pyrrolo[1,2-c]purin-5-ium-5-olate

6-amino-10,10-dihydroxy-4-[(c-hydroxycarbonimidoyloxy)methyl]-2-imino-1h,3h,3ah,4h,8h,9h-pyrrolo[1,2-c]purin-5-ium-5-olate

C10H17N7O5 (315.1291)


   

n-{3-[(4z)-2-hydroxy-1-[(1e)-2-(4-hydroxyphenyl)ethenyl]-5-oxoimidazol-4-ylidene]propyl}guanidine

n-{3-[(4z)-2-hydroxy-1-[(1e)-2-(4-hydroxyphenyl)ethenyl]-5-oxoimidazol-4-ylidene]propyl}guanidine

C15H17N5O3 (315.1331)


   

n-(3-{2-hydroxy-1-[2-(4-hydroxyphenyl)ethenyl]-5-oxoimidazol-4-ylidene}propyl)guanidine

n-(3-{2-hydroxy-1-[2-(4-hydroxyphenyl)ethenyl]-5-oxoimidazol-4-ylidene}propyl)guanidine

C15H17N5O3 (315.1331)